- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- February 2025
- 252 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2025
- 233 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 136 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 215 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 143 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 160 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 161 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 164 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 156 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 185 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 136 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 138 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 130 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 164 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 134 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 162 Pages
Global
From €2275EUR$2,500USD£1,951GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more